San Donato Hospital
Why choose Italy for holmium laser enucleation of the prostate?
Access advanced Holmium Laser Enucleation of the Prostate solutions in trusted clinics .
| Italy | Turchia | Austria | |
| Holmium Laser Enucleation of the Prostate | - | da $3,000 | da $7,500 |
Revisionato medicalmente da
Fahad MawloodBookimed non aggiunge costi extra ai prezzi di Holmium Laser Enucleation of the Prostate. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica per la tua Holmium Laser Enucleation of the Prostate al tuo arrivo.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali in Holmium Laser Enucleation of the Prostate e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di Holmium Laser Enucleation of the Prostate.
Day 1: Arrival
Day 2: Pre-operation
Day 3: Operation
Day 4: Post-operation
Day 5-7: Recovery at the hotel
Week 2-4: Rehabilitation
Week 5: Return to work
Note: Each patient"s recovery process may vary based on individual health conditions and the complexity of the operation.
Over 8,000 urology surgeries performed – Prof. Montorsi is a top Italian expert in minimally invasive and robotic techniques at San Raffaele.
Specializes in minimally invasive prostate treatments – Dr. Saltutti uses robotic and laparoscopic techniques at Maria Cecilia Hospital.
Dr. Alessandro Calarco is a skilled urologist with expertise in minimally invasive and endourological procedures. He performs percutaneous lithotripsy, ureterorenoscopy, tumor ablation, and advanced reconstructive surgeries. Dr. Calarco has received international recognition for his clinical work and research. He completed advanced training in Sweden and the UK.
Dr. Calarco graduated with top honors from Università Cattolica del Sacro Cuore in Rome. He completed his Urology specialization and earned a PhD in Oncological Urology at the same university. His research focuses on prostate cancer biomarkers and exosomes. He has also helped develop clinical protocols for hormone-refractory prostate cancer.
He serves as National Head of Urology for SPIGC and is a member of the European Board of Urology. Dr. Calarco holds an international patent for a device that improves percutaneous nephrolithotripsy. He has published extensively and received several awards for surgical innovation and education.